Harrow (HROW) Cash from Financing Activities (2011 - 2026)

Harrow (HROW) recorded quarterly Cash from Financing Activities of $48.9 million in Q1 2026, up 1069.71% quarter-over-quarter from -$5.0 million in Q4 2025, and up 212560.87% on a YoY basis from N/an in Q1 2025.

Harrow (HROW) Cash from Financing Activities (2011 - 2026) Analysis & Trends

Harrow's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $48.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 212560.87% year-over-year to $48.9 million; the TTM figure through Mar 2026 stood at $36.2 million (up 23.18% YoY), while the FY2025 annual figure was -$12.7 million, down 144.6% from the prior year.
  • Cash from Financing Activities was $48.9 million for Q1 2026 at Harrow, up from -$5.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $64.2 million in Q3 2023 to a low of -$12.7 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged $15.3 million across 5 years, with a median of $48000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities soared 2751500.0% in 2022, then sank 17452.05% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $55.0 million in 2022, then plunged by 100.03% to -$18000.0 in 2023, then soared by 166683.33% to $30.0 million in 2024, then slumped by 116.82% to -$5.0 million in 2025, then soared by 1069.71% to $48.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at $48.9 million (Q1 2026), -$5.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 48.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 48.91 Mn
Mar 31, 2026 48.91 Mn
Dec 31, 2025 -5.04 Mn
Dec 31, 2025 -5.04 Mn
Sep 30, 2025 4.96 Mn
Sep 30, 2025 4.96 Mn
Jun 30, 2025 -12.67 Mn
Jun 30, 2025 -12.67 Mn
Mar 31, 2025 23,000.00
Mar 31, 2025 23,000.00
Dec 31, 2024 29.99 Mn
Dec 31, 2024 29.99 Mn
Sep 30, 2024 -721,000.00
Sep 30, 2024 -721,000.00
Jun 30, 2024 73,000.00
Jun 30, 2024 73,000.00
Mar 31, 2024 -809,000.00
Mar 31, 2024 -809,000.00
Dec 31, 2023 -18,000.00
Dec 31, 2023 -18,000.00